• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Chavant Capital Acquisition Corp.

    2/11/22 9:20:06 PM ET
    $CLAY
    Blank Checks
    Finance
    Get the next $CLAY alert in real time by email
    SC 13G 1 d290201dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ___)*

     

     

    Chavant Capital Acquisition Corp.

    (Name of Issuer)

    ORDINARY SHARES, PAR VALUE

    $0.0001 PER SHARE

    (Title of Class of Securities)

    CUSIP: G2058L103

    (CUSIP Number)

    FEBRUARY 10, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☒

    Rule 13d-l(b)

     

      ☐

    Rule 13d-l(c)

     

      ☐

    Rule 13d-l(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP: G2058L103

     

      (1)   

    Names of reporting persons

     

    ARENA CAPITAL ADVISORS, LLC – CA

      (2)  

    Check the appropriate box if a member of a group (see instructions)

    (a)  ☒        (b)  ☐

     

      (3)  

    SEC use only

     

      (4)  

    Citizenship or place of organization

     

    DELAWARE

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person

    with:

       (5)    

    Sole voting power

     

    875,000

       (6)   

    Shared voting power

     

       (7)   

    Sole dispositive power

     

    875,000

       (8)   

    Shared dispositive power

     

      (9)  

    Aggregate amount beneficially owned by each reporting person

     

    875,000

    (10)  

    Check box if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    (11)  

    Percent of class represented by amount in Row (9)

     

    5.00%

    (12)  

    Type of reporting person (see instructions)

     

    IA


    CUSIP: G2058L103

     

      (1)   

    Names of reporting persons

     

    ARENA CAPITAL FUND, LP – SERIES 3

      (2)  

    Check the appropriate box if a member of a group (see instructions)

    (a)  ☒        (b)  ☐

     

      (3)  

    SEC use only

     

      (4)  

    Citizenship or place of organization

     

    DELAWARE

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person

    with:

       (5)    

    Sole voting power

     

    875,000

       (6)   

    Shared voting power

     

       (7)   

    Sole dispositive power

     

    875,000

       (8)   

    Shared dispositive power

     

      (9)  

    Aggregate amount beneficially owned by each reporting person

     

    875,000

    (10)  

    Check box if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    (11)  

    Percent of class represented by amount in Row (9)

     

    5.00%

    (12)  

    Type of reporting person (see instructions)

     

    IA


    CUSIP: G2058L103

     

      (1)   

    Names of reporting persons

     

    ARENA CAPITAL FUND, LP – SERIES 4

      (2)  

    Check the appropriate box if a member of a group (see instructions)

    (a)  ☒        (b)  ☐

     

      (3)  

    SEC use only

     

      (4)  

    Citizenship or place of organization

     

    DELAWARE

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person

    with:

       (5)    

    Sole voting power

     

    875,000

       (6)   

    Shared voting power

     

       (7)   

    Sole dispositive power

     

    875,000

       (8)   

    Shared dispositive power

     

      (9)  

    Aggregate amount beneficially owned by each reporting person

     

    875,000

    (10)  

    Check box if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    ☐

    (11)  

    Percent of class represented by amount in Row (9)

     

    5.00%

    (12)  

    Type of reporting person (see instructions)

     

    IA


    SCHEDULE 13G

    Item 1(a) Name of issuer: Chavant Capital Acquisition Corp.

    Item 1(b) Address of issuer’s principal executive offices: 445 PARK AVE, 9TH FLOOR, NEW YORK, NY 10022

    2(a) Name of person filing:

    ARENA CAPITAL ADVISORS, LLC – CA

    ADDITONAL REPORTING PERSONS: Series 3 and 4 of Arena Capital Fund, LP

    SEE ATTACHED FOR LIST WITH SEPARATE ENTRY FOR EACH ADDITONAL REPORTING PERSON

    2(b) Address or principal business office or, if none, residence:

    12121 WILSHIRE BLVD. STE 1010, LOS ANGELES, CA 90025

    2(c) Citizenship:

    DELAWARE

    2(d) Title of class of securities:

    ORDINARY SHARES

    2(e) CUSIP No.:

    G2058L103

     

    Item 3.

    If this statement is filed pursuant to §§240.13d-1 (b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 780);
    (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)    ☐    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)    ☒    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
    (f)    ☐    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
    (g)    ☐    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
    (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)    ☐    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
    (k)    ☐    Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                             

     

    Item 4.

    Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a)

    Amount beneficially owned: 875,000.

     

    (b)

    Percent of class: 5.00%

     

    (c)

    Number of shares as to which the person has:


      (i)

    Sole power to vote or to direct the vote 875,000.

     

      (ii)

    Shared power to vote or to direct the vote

     

      (iii)

    Sole power to dispose or to direct the disposition of 875,000.

     

      (iv)

    Shared power to dispose or to direct the disposition of

     

    Item 5.

    Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following  ☐. N/A

    Dissolution of a group requires a response to this item.

     

    Item 6.

    Ownership of More than 5 Percent on Behalf of Another Person.

    N/A

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    N/A

     

    Item 8.

    Identification and Classification of Members of the Group.

    Members of group include private funds managed by Arena Capital Advisors, LLC, over which it has sole voting and dispositive power.

     

    Item 9.

    Notice of Dissolution of Group.

    N/A

     

    Item 10.

    Certifications

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect other than activities solely in connection with a nomination under §240.14a-11.

    Signatures

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 11, 2022       ARENA CAPITAL ADVISORS, LLC – CA
        Signature:  

    /s/ SANIJE PERRETT

        Name:   SANIJE PERRETT
        Title:   MEMBER
          SIGNATURES OF ADDITIONAL REPORTING
          PERSONS CONTINUED ON ATTACHED


    ADDITIONAL REPORTING PERSONS

    ARENA CAPITAL FUND, LP – SERIES 3

    12121 WILSHIRE BLVD., SUITE 1010

    LOS ANGELES, CA 90025

    ARENA CAPITAL FUND, LP – SERIES 4

    12121 WILSHIRE BLVD., SUITE 1010

    LOS ANGELES, CA 90025


    ADDITIONAL REPORTING PERSONS’ SIGNATURES
    ARENA CAPITAL FUND, LP – SERIES 3
    BY:  

    /s/ SANIJE PERRETT

      SANIJE PERRETT, PRESIDENT OF GENERAL
      PARTNER
    ARENA CAPITAL FUND, LP – SERIES 4
    BY:  

    /s/ SANIJE PERRETT

      SANIJE PERRETT, PRESIDENT OF GENERAL
      PARTNER
    Get the next $CLAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLAY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CLAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chavant Capital Partners Llc disposed of 658,631 shares, bought $1,997,370 worth of shares (199,737 units at $10.00) and acquired 272,182 shares, decreasing direct ownership by 12% to 1,394,101 units (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 6:01:22 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    SEC Filings

    See more
    • SEC Form NT 10-Q filed by Chavant Capital Acquisition Corp.

      NT 10-Q - MOBIX LABS, INC (0001855467) (Filer)

      2/15/24 4:52:22 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form 424B3 filed by Chavant Capital Acquisition Corp.

      424B3 - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 8:55:31 PM ET
      $CLAY
      Blank Checks
      Finance
    • Chavant Capital Acquisition Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Leadership Update, Financial Statements and Exhibits

      8-K - MOBIX LABS, INC (0001855467) (Filer)

      1/23/24 5:25:19 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chavant Capital Acquisition Corp. (Amendment)

      SC 13G/A - MOBIX LABS, INC (0001855467) (Subject)

      2/9/24 7:26:55 AM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13D filed by Chavant Capital Acquisition Corp.

      SC 13D - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:21:14 PM ET
      $CLAY
      Blank Checks
      Finance
    • SEC Form SC 13G filed by Chavant Capital Acquisition Corp.

      SC 13G - Chavant Capital Acquisition Corp. (0001855467) (Subject)

      1/2/24 5:18:58 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Goerner Frederick C was granted 317,244 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:51:34 PM ET
      $CLAY
      Blank Checks
      Finance
    • Peterson James J was granted 2,404,845 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:50:44 PM ET
      $CLAY
      Blank Checks
      Finance
    • Carpou Bill was granted 73,752 shares (SEC Form 4)

      4 - Chavant Capital Acquisition Corp. (0001855467) (Issuer)

      12/26/23 9:48:00 PM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mobix Labs, Inc. Closes Business Combination with Chavant Capital Acquisition Corp., Becomes Publicly Traded

      IRVINE, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, today announced that its previously announced business combination with Chavant Capital Acquisition Corp. ("Chavant") (NASDAQ:CLAY) has closed, resulting in Mobix Labs becoming a publicly traded company. The business combination and all other proposals presented were approved at an extraordinary general meeting of Chavant shareholders held on December 18, 2023. In connection with the completion of the business combination,

      12/21/23 8:59:37 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Effectiveness of Registration Statement on Form S-4

      IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G infrastructure, satellite communications and defense industries, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (the "SEC") has declared effective the Registration Statement on Form S-4 (as amended, the "Registration Statement") filed by Chavant and relating to the previously announced proposed business combination between Mobix Labs and Chavant (the "Bus

      11/21/23 4:07:00 PM ET
      $CLAY
      Blank Checks
      Finance
    • Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Filing of Registration Statement on Form S-4 in Connection With Proposed Business Combination

      IRVINE, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. ("Mobix Labs" or the "Company"), an innovative provider of next generation wireless mmWave 5G and connectivity solutions, and Chavant Capital Acquisition Corp. (NASDAQ:CLAY) ("Chavant"), a publicly-traded special purpose acquisition company, announced today the filing by Chavant with the U.S. Securities and Exchange Commission ("SEC") of a registration statement on Form S-4 (the "Registration Statement") on April 7, 2023, relating to the previously announced proposed business combination of Chavant and Mobix Labs. The Registration Statement contains a preliminary proxy statement/prospectus in connection with the previousl

      4/10/23 8:00:00 AM ET
      $CLAY
      Blank Checks
      Finance

    $CLAY
    Leadership Updates

    Live Leadership Updates

    See more
    • LinKinVax Appoints Dr. Jiong Ma as Independent Board Member

      An international expert in the financing and growth of high tech businesses LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of Dr. Jiong Ma as independent board member. "As we enter the clinical stages of a number of drug candidates (HPV, Covid) resulting from our innovative vaccine platform, I am delighted to welcome Dr. Jiong Ma as an addition to our board. With a longstanding focus on the financing and growth of high tech businesses, her role will be to support us in our platform development strategy and to help us achieve our ambitions on a global scale. Dr. Jiong Ma benefits

      5/4/22 6:00:00 AM ET
      $AVXL
      $CLAY
      $SES
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Blank Checks
      Finance